Importantly, further results showed that ApoE4 significantly downregulates ACE2 protein expression in vitro and in vivo and consequently decreases the conversion of Ang II to Ang 1–7, which may provide a potential mechanism by which ApoE4 is associated with increased severity of COVID-19 (Fig. 9). The gene discussed is APOE; the disease is COVID-19.